Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis

被引:0
|
作者
Liu, Zhiyao [1 ]
Huang, Hailiang [1 ]
Yu, Ying [2 ]
Jia, Yuqi [1 ]
Li, Lingling [1 ]
Shi, Xin [1 ]
Wang, Fangqi [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan 250355, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan 250355, Shandong, Peoples R China
关键词
Colchicine; coronavirus disease-19; non-small cell lung cancer; network pharmacology; bioinformatics analysis; molecular docking; molecular dynamics simulation; INTERLEUKIN-17; DISEASE; LESIONS; GENES; IL-17; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colchicine is an alkaloid with antitumor effect isolated from Colchicum autumnale plants, it has been reported in multiple studies as a potential treatment for coronavirus disease-19 and this study applied network pharmacology and bioinformatics analysis to explore the potential mechanism of colchicine against non-small cell lung cancer and coronavirus disease-19. The R software was used to determine the differentially expressed genes of non-small cell lung cancer/coronavirus disease-19, and carry out prognostic analysis and clinical analysis of the differentially expressed genes, the targets of colchicine were obtained from various databases, the protein-protein interaction network of intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 was constructed, enrichment analysis of gene ontology and kyoto encyclopedia of genes and genomes pathways was performed by Metascape database and the molecular docking and molecular dynamics simulation were completed. We obtained a total of 716 differentially expressed genes and identified 13 potential prognostic genes associated with the clinical characterization of non-small cell lung cancer/coronavirus disease-19 patients. C-C motif chemokine ligand 2, toll like receptor 4, intercellular adhesion molecule 1, peroxisome proliferator activated receptor gamma, interleukin 17A, interferon gamma, angiotensin I converting enzyme, fos proto-oncogene, nuclear factor kappa B inhibitor alpha, TIMP metallopeptidase inhibitor 1 and secreted phosphoprotein 1 were core targets. The intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 were mainly enriched in biological processes such as inflammatory response, response to cytokine and response to lipopolysaccharide, as well as signal pathways such as interleukin 17 signaling pathway, hypoxia inducible factor 1 signaling pathway and nucleotide binding oligomerization domain-like receptor signaling pathway. The results of molecular docking showed that the colchicine is better combined with the core targets. Analysis of molecular dynamics simulation showed that the protein and ligand form a stabilizing effect. Based on bioinformatics analysis and network pharmacology, we obtained biomarkers that may be used for the prognosis of non-small cell lung cancer/coronavirus disease-19 patients and revealed that colchicine may play a potential role in the treatment of non-small cell lung cancer/coronavirus disease-19 by regulating multiple targets and multiple signaling pathways and participating in multiple biological processes.
引用
收藏
页码:199 / 216
页数:18
相关论文
共 50 条
  • [21] Exploring the Mechanism of Action of Resveratrol in the Treatment of Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation
    Dong Y.
    Niu Y.
    Zhang Y.
    Huo R.
    Liu Q.
    Tian X.
    Science and Technology of Food Industry, 2024, 45 (01) : 28 - 36
  • [22] Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer
    Xu, Wei
    Zhao, Jing
    Luan, Fang
    Zhang, Zhizhao
    Liu, Lei
    Zhao, Hui
    Feng, Bin
    Fu, Guobin
    CANCER MEDICINE, 2024, 13 (08):
  • [23] A bioinformatics investigation into the pharmacological mechanisms of javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies
    Mengwei Ni
    Xinkui Liu
    Ziqi Meng
    Shuyu Liu
    Shanshan Jia
    Yingying Liu
    Wei Zhou
    Jiarui Wu
    Jingyuan Zhang
    Siyu Guo
    Jialin Li
    Haojia Wang
    Xiaomeng Zhang
    BMC Complementary Medicine and Therapies, 20
  • [24] IMPACT OF COVID-19 ON IMMUNOTHERAPY UTILIZATION IN METASTATIC NON-SMALL CELL LUNG CANCER
    Chopra, P.
    Zhai, Y.
    Myers, M.
    VALUE IN HEALTH, 2020, 23 : S421 - S421
  • [25] Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic
    Karaman, Elanur
    Ulas, Arife
    Onder, Arif Hakan
    Deligonul, Adem
    Orhan, Sibel O.
    Pekcolaklar, Atilla
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [26] Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
    Hekimoglu, Baris
    Beyoglu, Muhammet Ali
    ASIAN JOURNAL OF SURGERY, 2022, 45 (08) : 1553 - 1558
  • [27] The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking
    Xie, Rui-fei
    Song, Zi-yu
    Xu-shao, Lu-yao
    Huang, Jin-ge
    Zhao, Ting
    Yang, Zi
    MEDICINE, 2022, 101 (52) : E32555
  • [28] A bioinformatics investigation into the pharmacological mechanisms of java']javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies
    Ni, Mengwei
    Liu, Xinkui
    Meng, Ziqi
    Liu, Shuyu
    Jia, Shanshan
    Liu, Yingying
    Zhou, Wei
    Wu, Jiarui
    Zhang, Jingyuan
    Guo, Siyu
    Li, Jialin
    Wang, Haojia
    Zhang, Xiaomeng
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 174
  • [29] Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer
    Sun, Qiuwen
    Li, Xia
    Xu, Muchen
    Zhang, Li
    Zuo, Haiwei
    Xin, Yong
    Zhang, Longzhen
    Gong, Ping
    FRONTIERS IN GENETICS, 2020, 11
  • [30] Identification of key genes in non-small cell lung cancer by bioinformatics analysis
    Zhang, Li
    Peng, Rui
    Sun, Yan
    Wang, Jia
    Chong, Xinyu
    Zhang, Zheng
    PEERJ, 2019, 7